Contract DAMD1703C0018
Nirx Medical Technologies Llc · Department Of Defense · December 13, 2002
Nirx Medical Technologies Llc was awarded a federal contract by Department Of Defense (Department Of The Army) on December 13, 2002 for $844,000 of work in research and development in biotechnology. Performance is in Glen Head, NY. It was awarded under a small business set-aside. The contract has been modified 5 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on March 3, 2008.
Contract details
- PIID
- DAMD1703C0018
- Award type
- Dca
- Pricing
- Firm Fixed Price
- Set-aside
- Small Business Set Aside - Total
- Competition
- Full And Open Competition After Exclusion Of Sources
- NAICS
- 541711 · Research And Development In Biotechnology
- Product / service
- Other Medical (Basic)
- Place of performance
- Glen Head, NY
- First action
- December 13, 2002
- Latest action
- March 3, 2008
Description
SBIR PHASE II
Modification timeline
-
March 3, 2008Mod P00007$0
-
November 16, 2006Mod P00006SERVICES$0
-
November 24, 2004Mod P00003$346.9K
-
November 6, 2003Mod P00002$381.3K
-
August 14, 2003Mod P00001$46.0K
-
December 13, 2002Base award200305!000077!2100!MD17 !US ARMY MEDICAL RESEARCH ACQ ACT!DAMD1703C0018 !A!N! !N! !20021213!20030715!117953617!117953617!117953617!N!NIRX ME$69.9K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Bluehalo, Llc | Department Of Defense | November 4, 2025 | $0 |
| Bluehalo, Llc | Department Of Defense | November 4, 2025 | $0 |
| Bluehalo, Llc | Department Of Defense | November 4, 2025 | $3.00M |
| Inbios International Inc | Department Of Defense | September 22, 2025 | $25.66M |
| Dynport Vaccine Company Llc | Department Of Defense | September 12, 2025 | $117.63M |
| Westat, Inc. | Department Of Defense | August 28, 2025 | $22.21M |
Top contractors in NAICS 541711
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Alliance For Energy Innovation, Llc | 2 | $10.68B |
| 2 | Emergent Product Development Gaithersburg Inc. | 7 | $1.63B |
| 3 | Janssen Pharmaceuticals, Inc. | 2 | $1.05B |
| 4 | Regeneron Pharmaceuticals Inc | 4 | $1.01B |
| 5 | Siga Technologies, Inc. | 3 | $560.59M |
| 6 | Battelle National Biodefense Institute, Llc | 106 | $469.31M |
| 7 | Glaxosmithkline, Llc | 6 | $321.65M |
| 8 | Merck Sharp & Dohme Llc | 3 | $309.72M |
| 9 | Sri International | 130 | $258.61M |
| 10 | American Type Culture Collection | 7 | $243.18M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract DAMD1703C0018?
Contract DAMD1703C0018 is a federal contract awarded to Nirx Medical Technologies Llc by Department Of Defense on December 13, 2002 for $844,000 of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY. It has been modified 5 times since the base award.
Who won contract DAMD1703C0018?
Nirx Medical Technologies Llc won contract DAMD1703C0018 from Department Of Defense.
How much is contract DAMD1703C0018 worth?
Contract DAMD1703C0018 has obligated $844,000 to date.